We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$324B
| $119M | 0.54% |
1,532,400
-123,440
| -7% | -$9.18M |
|
27
Palo Alto Networks
PANW
$264B
| $119M | 0.53% |
1,924,242
-57,072
| -3% | -$3.38M |
|
28
Perrigo
PRGO
$1.4B
| $117M | 0.52% |
2,541,300
+1,343,509
| +112% | +$59.6M |
|
29
Walmart Inc
WMT
$871B
| $114M | 0.51% |
2,417,997
+1,652,355
| +216% | +$77M |
|
30
JD.com
JD
$40.8B
| $113M | 0.51% |
1,422,073
+397,748
| +39% | +$29.9M |
|
31
BILL Holdings
BILL
$4.33B
| $113M | 0.51% |
616,900
+536,066
| +663% | +$84M |
|
32
AstraZeneca
AZN
$263B
| $108M | 0.49% |
902,012
-874,412
| -49% | -$95.9M |
|
33
Nice
NICE
$5.29B
| $108M | 0.49% |
436,200
+2,300
| +0.5% | +$530K |
|
34
PUT
Invesco QQQ Trust
QQQ
$450B
| $106M | 0.48% |
300,000
-500,000
| -63% | -$168M |
|
35
Regeneron Pharmaceuticals
REGN
$68.8B
| $105M | 0.47% |
+188,700
| New | +$95.6M |
|
36
Arista Networks
ANET
$219B
| $102M | 0.46% |
4,512,000
+4,128,000
| +1,075% | +$86.2M |
|
37
Netflix
NFLX
$292B
| $101M | 0.45% |
1,906,020
-359,290
| -16% | -$18.4M |
|
|
SMAR
38
DELISTED
Smartsheet Inc.
SMAR
| $100M | 0.45% |
+1,388,408
| New | +$86.6M |
|
39
Alibaba
BABA
$269B
| $99.5M | 0.45% |
438,764
+182,897
| +71% | +$40.6M |
|
40
Cisco
CSCO
$450B
| $99.2M | 0.45% |
1,871,600
+1,610,678
| +617% | +$84.7M |
|
|
41
United Therapeutics
UTHR
$26.3B
| $99.1M | 0.45% |
+552,400
| New | +$105M |
|
|
HZNP
42
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $98.9M | 0.44% |
+1,055,871
| New | +$97.2M |
|
43
Microsoft
MSFT
$2.84T
| $98.7M | 0.44% |
364,503
-231,552
| -39% | -$58.9M |
|
44
Copart
CPRT
$25.9B
| $96.4M | 0.43% |
2,924,980
-1,233,492
| -30% | -$38.2M |
|
45
Global Payments
GPN
$22.1B
| $90.2M | 0.41% |
480,944
+399,137
| +488% | +$80.3M |
|
|
SBNY
46
DELISTED
Signature Bank
SBNY
| $87.4M | 0.39% |
355,782
-85,002
| -19% | -$20.6M |
|
47
Biogen
BIIB
$29.9B
| $85M | 0.38% |
245,506
+130,106
| +113% | +$39.4M |
|
48
Arvinas
ARVN
$518M
| $84.7M | 0.38% |
1,099,600
-28,500
| -3% | -$1.98M |
|
49
CMS Energy
CMS
$23.1B
| $82.9M | 0.37% |
1,403,908
+1,242,800
| +771% | +$77.3M |
|
50
Performance Food Group
PFGC
$17.5B
| $82.1M | 0.37% |
1,692,925
+1,210,400
| +251% | +$63.9M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.